28336141|t|The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitis
28336141|a|A series of potent, competitive and highly selective kynurenine monooxygenase inhibitors have been discovered via a substrate -based approach for the treatment of acute pancreatitis. The lead compound demonstrated good cellular potency and clear pharmacodynamic activity in vivo.
28336141	38	64	kynurenine 3-monooxygenase	T103	UMLS:C0064449
28336141	65	75	inhibitors	T103	UMLS:C0014432
28336141	84	93	treatment	T058	UMLS:C0087111
28336141	97	115	acute pancreatitis	T038	UMLS:C0001339
28336141	169	193	kynurenine monooxygenase	T103	UMLS:C0064449
28336141	194	204	inhibitors	T103	UMLS:C0014432
28336141	249	257	approach	T082	UMLS:C0449445
28336141	266	275	treatment	T058	UMLS:C0087111
28336141	279	297	acute pancreatitis	T038	UMLS:C0001339
28336141	308	316	compound	T103	UMLS:C1706082
28336141	335	343	cellular	T017	UMLS:C0007634
28336141	362	377	pharmacodynamic	T038	UMLS:C0851347
28336141	387	394	in vivo	T082	UMLS:C1515655